OppenheimerFunds’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-105,810
| Closed | -$8.08M | – | 1850 |
|
|
2018
Q3 | $8.08M | Buy |
+105,810
| New | +$8.08M | 0.01% | 736 |
|
|
2017
Q4 | – | Sell |
-332,345
| Closed | -$17.7M | – | 1864 |
|
|
2017
Q3 | $17.7M | Sell |
332,345
-27,762
| -8% | -$1.48M | 0.02% | 608 |
|
|
2017
Q2 | $22.4M | Sell |
360,107
-2,447
| -0.7% | -$152K | 0.03% | 530 |
|
|
2017
Q1 | $24.6M | Buy |
362,554
+22,339
| +7% | +$1.51M | 0.03% | 514 |
|
|
2016
Q4 | $23.9M | Buy |
340,215
+7,024
| +2% | +$494K | 0.03% | 524 |
|
|
2016
Q3 | $23.6M | Sell |
333,191
-58,122
| -15% | -$4.12M | 0.03% | 521 |
|
|
2016
Q2 | $19.1M | Buy |
391,313
+61,513
| +19% | +$3.01M | 0.03% | 568 |
|
|
2016
Q1 | $20.9M | Buy |
329,800
+18,851
| +6% | +$1.19M | 0.03% | 550 |
|
|
2015
Q4 | $34.9M | Sell |
310,949
-62,822
| -17% | -$7.05M | 0.04% | 409 |
|
|
2015
Q3 | $36M | Sell |
373,771
-16,273
| -4% | -$1.57M | 0.05% | 399 |
|
|
2015
Q2 | $39.9M | Sell |
390,044
-119,113
| -23% | -$12.2M | 0.05% | 400 |
|
|
2015
Q1 | $31.6M | Buy |
509,157
+79,146
| +18% | +$4.91M | 0.04% | 480 |
|
|
2014
Q4 | $18.9M | Buy |
430,011
+88,893
| +26% | +$3.9M | 0.02% | 602 |
|
|
2014
Q3 | $19.3M | Buy |
341,118
+235,886
| +224% | +$13.4M | 0.02% | 577 |
|
|
2014
Q2 | $4.72M | Buy |
105,232
+1,942
| +2% | +$87.2K | 0.01% | 840 |
|
|
2014
Q1 | $5.05M | Buy |
+103,290
| New | +$5.05M | 0.01% | 837 |
|